Iron deficiency prevalence defined using a soluble transferrin receptor threshold of greater than 4·4 mg/L showed a very similar pattern, with the prevalence of iron-deficiency anaemia also higher in both screen-and-treat groups at day 84 (appendix pp 17–19). Here, TFRC is linked to Iron deficiency anemia.